SCHEMBL6172243

SCHEMBL6172243

CC(C)(C)[Si](OCc1cc(CO)cc(C(=O)O)c1)(c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MRGPRX4 Q96LA9 8/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TSHR P16473 1/20 0.36
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
RXRG P48443 1/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
XBP1 P17861 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
NR4A1 P22736 1/20 0.34
NR4A2 P43354 1/20 0.34
NR4A3 Q92570 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31124766 0.91 TSHR (0.35) SMN1; SMN2TSHRHTTPPARGPPARA
SCHEMBL21817202 0.86 MRGPRX4 (0.38) MEN1KMT2AMRGPRX4SMN1; SMN2RXRA
SCHEMBL6170674 0.85 HIF1A (0.44) MEN1KMT2AMRGPRX4TSHRNPC1
SCHEMBL16818604 0.84 TACR1 (0.34) MEN1KMT2AMRGPRX4SMN1; SMN2TSHR
SCHEMBL6170850 0.84 UNG (0.38) MEN1KMT2AMRGPRX4RXRARXRB
SCHEMBL8024443 0.82 MRGPRX4 (0.38) MRGPRX4SMN1; SMN2TSHRNPC1TP53
SCHEMBL9342265 0.82 RXRA (0.51) SMN1; SMN2RXRARXRBRXRGNPC1
SCHEMBL21817599 0.82 MRGPRX4 (0.35) MEN1KMT2AMRGPRX4
SCHEMBL5106543 0.81 CYP4F2 (0.42) MEN1KMT2ASMN1; SMN2TSHRMAPT
SCHEMBL2745018 0.81 PPARG (0.41) KMT2ATSHRRXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1192127-B1 SUBSTITUTED BENZAMIDE INHIBITORS OF RHINOVIRUS 3C PROTEASE AGOURON PHARMA (US) 2005-03-30 EP disclosed
US-6369226-B1 ENZYME INHIBITORS AGOURON PHARMACEUTICALS, INC. 2002-04-09 US disclosed